Related Experiment Videos
Mitochondrial DNA alterations in cancer.
William C Copeland1, Joseph T Wachsman, F M Johnson
1Laboratory of Molecular Genetics, National Institute of Environmental Health Sciences, P.O. Box 12233, Research Triangle Park, NC 27709, USA. copelan1@niehs.nih.gov
Cancer Investigation
|July 4, 2002
Summary
Mitochondrial DNA (mtDNA) mutations are present in various solid tumors and may drive cancer development. These genetic changes in mtDNA can increase oxidative stress, promoting tumor growth and progression.
Area of Science:
- Oncology
- Genetics
- Cell Biology
Background:
- Mitochondrial DNA (mtDNA) mutations are increasingly recognized in cancer cells.
- Genomic aberrations in mtDNA have been reported across numerous solid tumor types.
Purpose of the Study:
- To review mitochondrial genomic aberrations in common solid tumors.
- To discuss the role of mtDNA mutations and altered gene expression in carcinogenesis.
- To explore the link between mtDNA alterations, oxidative stress, and tumor development.
Main Methods:
- Literature review of studies reporting mtDNA mutations and expression alterations in solid tumors.
- Analysis of reported associations between mtDNA aberrations and carcinogenesis.
- Discussion of the proposed mechanisms involving reactive oxygen species.
Main Results:
- Mitochondrial DNA mutations are prevalent in breast, colon, stomach, liver, kidney, bladder, head/neck, and lung cancers.
- Altered expression of mtDNA-encoded genes, particularly those for the electron respiratory chain, is observed in solid tumors.
- Elevated expression may indicate mitochondrial adaptation to altered cellular energy demands.
Conclusions:
- Mitochondrial DNA mutations are implicated in the initiation and progression of carcinogenesis.
- Increased reactive oxygen species production due to mtDNA mutations contributes to persistent oxidative stress, favoring tumor development.
- Further research is warranted to elucidate the precise role of mtDNA alterations in cancer etiology.